A clearly recognized function of GSTs is their participation in antioxidative reactions together with the pivotal cellular antioxidant GSH in order to eliminate ROS and lipid hydroperoxides that accumulate in infected tissues (Figure 1) (Wagner et al., 2002)

Acetylcysteine solution, USP is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) Acetylcysteine solution is contraindicated in those patients who are sensitive to it
GLP-1 stands for glucagon-like peptide-1 , a hormone made in the intestines
Structurally it is derived from the GHRP-1 backbone but was deliberately modified to display a particularly narrow pharmacological profile